Combined Saussurea costus and doxorubicin suppresses breast cancer cell migration and proliferation through MMP2/MMP9 downregulation: in vitro and molecular docking evidence
Abstract Breast cancer (BC) is still a major cause of cancer-related death in women and requires new strategies for treatment. Saussurea costus (COS) has been reported to exhibit anticancer activity, and doxorubicin (DOX) is a commonly used chemotherapeutic agent. The relationship between their roles and BC cell behavior and regulation remains unclear. 28 compounds were identified in the COS ethanolic extract by LC–ESI–MS/MS. The docking and dynamics study of major compounds with MMP2 and MMP9 was performed. The effects of COS, DOX, and their combination on MCF7 and MDA-MB-231 cells were assessed for cytotoxicity, proliferation, migration (wound healing and transwell), colony formation, apoptosis (annexin-V), cell cycle, and MMP2/MMP9 mRNA expression. The main compounds found were apigenin (12.99%), medioresinol (8.32%), and luteolin (8.12%). Luteolin had the most negative value for protein binding (MMP2: − 8.90 kcal/mol; MMP9: − 9.50 kcal/mol) and medioresinol for mRNA binding. COS demonstrated dose-dependent cytotoxicity (IC 50 : 106.8 ± 1.43 μg/mL for MCF7; 116.8 ± 5.66 μg/mL for MDA-MB-231). The COS + DOX combination significantly reduced proliferation, migration, and colony formation, and increased apoptosis (MCF7: 34.85 ± 1.84%, MDA-MB-231: 45.56 ± 7.74%), and induced G2/M arrest in MDA-MB-231 cells. The expression of MMP2 and MMP9 mRNA was significantly downregulated. The COS + DOX treatment had a combinatorial effect in suppressing BC cell growth and migration, which was associated with downregulation of MMP2/MMP9 and induction of apoptosis. While these findings suggest a potential mechanistic role for MMP2/MMP9 downregulation, future studies measuring protein expression and enzymatic activity are required to confirm functional inhibition. Given its potential therapeutic significance, further in vivo studies are warranted.
Authors
- Jehan A. Hasanen
- Ahmed S. Warda
- Engy Mohsen (ORCID: https://orcid.org/0009-0007-5723-9476)
- Amany Elsayed Ragab (ORCID: https://orcid.org/0000-0001-8276-5397)
- Mohamed Fathy Youssef (ORCID: https://orcid.org/0000-0002-2019-4717)
- Ali El-Far
Institutions
- Suez Canal University (EG)
- Cairo University (EG)
- Damanhour University (EG)
- Tanta University (EG)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1038/s41598-026-72010-2
- Primary Topic
- Medicinal Plant Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Science and Technology Development Fund